Biography

Junwei Cui, male, 44 years old, postgraduate, graduated from Xinxiang Medical University, mainly studies drug-resistant tuberculosis complicated with diabetes, tuberculosis complicated with hepatitis, tuberculosis complicated with pulmonary infection, tuberculosis complicated with massive hemoptysis, pneumothorax, respiratory failure, working at the department of tuberculosis, The First Affiliated Hospital of Xinxiang Medical University, Henan Province, China.

Expertise

TB Diagnostics
Public Health

Key Impacts

Multicentre evaluation of tongue swabs using a new molecular point-of-care assay for TB diagnosis in China

Using tongue swabs and sputum specimens on Genewise-MTBC can exhibit non-inferior performance to Xpert MTB/RIF and enable decentralized implementation.

Source: Conference 2024
Development and clinical validation of a novel method for simultaneous rapid molecular drug susceptibility testing of rifampicin, isoniazid and fluoroquinolones

Reliance solely on RIF-resistance testing may overlook INH or FQs resistance, introducing uncertainty in treatment. Our novel method enables rapid combined resistance detection with excellent sensitivity and specificity, providing robust support for the early diagnosis of DR-TB patients.

Source: Conference 2024